BCBernadette Carroll

Bernadette Carroll

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bernadette Carroll has a total of 304 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification of TMEM263 as an ER-resident protein that controls early stages of lipid droplet biogenesis

    by Katy Yalci, Nafsika Chala, Joanna Moss, Connor MacDonald, Przemysław Zakrzewski, Phineas Smith, Rabia Sevil, Lana Willoughby, Seren Wonklyn, Thomas Andrews, et al.

    Cell and organismal growth is controlled not only by the availability of nutrients, but also the ability to dynamically sense and respond to changes in metabolic demand. We have identified a protein, TMEM263 (also known as C12orf23) as a mechanistic link between growth and lipid metabolism. TMEM263 was discovered in a screen as an ER-resident protein, and we have characterised its role as both necessary and sufficient for lipid droplet formation. TMEM263 has two transmembrane domains that fold into a dynamic alpha hairpin which are essential for its localisation to the ER and to support lipid droplet accumulation. Functionally, we propose that TMEM263 can interact with and support the condensation of neutral lipids in a bilayer to promote lipid droplet formation and growth. Consistently, loss of TMEM263 in cells and in zebrafish significantly impairs lipid droplet accumulation. Loss of TMEM263 protein function in vivo is associated with organismal growth defects and proportional dwarfism and our study provides a mechanistic understanding linking these phenotypes to impaired lipid droplet biology.

  • Open Access

    Senescent myoblasts exhibit ROS-dependent Akt-mTORC1 dysregulation and are susceptible to reductive stress-induced cell death

    by Vladimir Belhac, Alex Dillingham, Emilia Coward, Bradley Teal, Mark C. Turner, Stephanie D. Gagnon, Jiani Qian, Harry Wilford, Ella Warren, Natalie Moger, et al.

    Ageing is characterised by the accumulation of senescent cells. Owing to their irreversible cell-cycle arrest, these cells lack the capacity to replenish the stem cell pool and regenerate tissue, while their pro-inflammatory secretome propagates senescence in a paracrine manner. Much of the senescent phenotype has been attributed to dysregulated mTORC1 signalling, a key regulator of protein synthesis implicated in organismal ageing. Nonetheless, the mechanism underlying this dysregulation is poorly understood and limited to a few selected cell types. Here, we show that mTORC1 dysregulation is also a characteristic of senescent muscle precursor cells, and in contrast to reports in other cell types, senescent myoblasts do not rely on lysosomal nutrient liberation to sustain mTORC1 activity. Instead, they appear to depend on the PI3K/Akt pathway, which is upregulated in these cells. Exogenous antioxidants were identified to alleviate PI3K/Akt/mTORC1 signalling, while exogenous ROS has the capacity to activate mTORC1, supporting a model in which ROS acts upstream of this pathway in senescent myoblasts. Moreover, antioxidants were able to suppress the expression of pro-inflammatory cytokines and enhance the differentiation of senescent myoblasts. Interestingly, prolonged antioxidant treatment led to increased cell death in senescent but not proliferating myoblasts, suggesting they are more prone to reductive stress-induced cell death. We propose that, in vitro , the antioxidant capacity of many plant-derived compounds may underlie their reported benefits as therapeutics targeting senescent cells (senotherapeutics). Together, our findings provide novel insights into mTORC1-dependent regulation of the senescent phenotype and highlight the role of redox modulation in senotherapeutic strategies.

  • Open Access

    The growth-promoting protein TMEM263 is an ER resident that controls early stages of lipid droplet biogenesis

    by Katy Yalci, Nafsika Chala, Joanna Moss, Przemysław Zakrzewski, Rabia Sevil, Lana Willoughby, Seren Wonklyn, Thomas Andrews, Chrissy L Hammond, Robin A. Corey, et al.

    Cell and organismal growth is controlled not only by the availability of nutrients, but also the ability to dynamically sense and respond to changes in metabolic demand. We have identified a protein, TMEM263 (also known as C12orf23) as a new mechanistic link between growth and lipid metabolism. TMEM263 was discovered in a screen as an ER-resident protein, and we have characterised its role as both necessary and sufficient for lipid droplet formation. TMEM263 has two transmembrane domains that fold into a hairpin structure which are essential for its localisation to the ER and to lipid droplets. Functionally, we propose that TMEM263 can interact with and support the condensation of neutral lipids in a bilayer to promote lipid droplet formation and growth. Consistently, loss of TMEM263 in cells and in zebrafish significantly impairs lipid droplet formation. Loss of TMEM263 protein function in vivo is associated with organismal growth defects and proportional dwarfism and our study provides a mechanistic understanding linking these phenotypes to impaired lipid droplet biology.

  • Open Access

    Senescent cell survival relies on upregulation of lysosomal quality control mechanisms

    by Rachel Curnock, Bernadette Carroll

    The accumulation of senescent cells is a key mediator of tissue and organismal ageing. Persistent activation of the growth regulator, mTORC1, even in the absence of growth factors and amino acids, supports senescence phenotypes, such as increased cell size and secretion of inflammatory factors. Here we extend this finding to show that senescence is associated with lysosomal accumulation of the low-density lipoprotein receptor (LDLR) and a failure of mTORC1 signalling to respond to changes in cholesterol. These observations are reflective of a broader dysfunction through the endo-lysosomal pathway, with Rab GTPases and phosphoinositides localised to atypical hybrid organelles. We propose that endosomal mistrafficking, in concert with increased autophagy and elevated lysosomal pH are contributing to an accumulation of undegraded material and lysosomal membrane damage. Our data indicate that in response to lysosomal dysfunction, senescent cells not only upregulate TFEB/TFE3-dependent lysosomal quality control but also upregulate lysosomal repair via PI4K2A-dependent PITT pathway. Perturbation of the lipid transport machinery required for lysosomal repair caused senescent cell death, revealing that targeting mechanisms of lysosomal repair has senolytic potential.


  • Open Access

    Senescence in the ageing skin: a new focus on mTORC1 and the lysosome

    by Phineas Smith, Bernadette Carroll

    Ageing is defined as the progressive loss of tissue function and regenerative capacity and is caused by both intrinsic factors i.e. the natural accumulation of damage, and extrinsic factors i.e. damage from environmental stressors. Cellular senescence, in brief, is an irreversible exit from the cell cycle that occurs primarily in response to excessive cellular damage, such as from ultraviolet (UV) exposure and oxidative stress, and it has been comprehensively demonstrated to contribute to tissue and organismal ageing. In this review, we will focus on the skin, an organ which acts as an essential protective barrier against injury, insults, and infection. We will explore the evidence for the existence and contribution of cellular senescence to skin ageing. We discuss the known molecular mechanisms driving senescence in the skin, with a focus on the dysregulation of the master growth regulator, mechanistic Target of Rapamycin Complex 1 (mTORC1). We explore the interplay of dysregulated mTORC1 with lysosomes and how they contribute to senescence phenotypes.


  • Open Access

    Table S5 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

    by Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Shan E. Ahmed Raza, Tom Lund, Ayse U. Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P. Chandrasekharan, Christodoulos P. Pipinikas, et al.

    Pathway analysis comparing the illumina and Affymetrix datasets as described in Supplementary Methods.

  • Open Access

    Table S4 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

    by Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Shan E. Ahmed Raza, Tom Lund, Ayse U. Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P. Chandrasekharan, Christodoulos P. Pipinikas, et al.

  • Open Access

    Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

    by Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Shan E. Ahmed Raza, Tom Lund, Ayse U. Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P. Chandrasekharan, Christodoulos P. Pipinikas, et al.

    Immune cell deconvolution from molecular data. Relative proportions of immune cell subtypes are predicted from gene expression data using the Danaher method, and from methylation data using methylCIBERSORT. Differences between progressive and regressive groups are reported here.

  • Open Access

    Supplementary Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

    by Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Shan E. Ahmed Raza, Tom Lund, Ayse U. Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P. Chandrasekharan, Christodoulos P. Pipinikas, et al.

  • Open Access

    Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

    by Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Shan E. Ahmed Raza, Tom Lund, Ayse U. Akarca, Rachel Rosenthal, Lukas Kalinke, Deepak P. Chandrasekharan, Christodoulos P. Pipinikas, et al.